Moderna Moves into Phase II Testing of COVID-19 Vaccine Candidate

Stéphane Bancel, Moderna’s chief executive officer, said the Phase II study is a crucial step in advancing the vaccine candidate as the company looks toward the goal of moving into Phase III.